Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Freeline Therapeutics Holdings plc
About FRLN
Freeline Therapeutics Holdings plc is a clinical-stage biotechnology company. The Company is developing transformative adeno-associated virus (AAV) vector-mediated gene therapies for patients suffering from chronic debilitating diseases. It uses its rationally designed AAV vector and capsid (AAVS3), along with novel promoters and transgenes, to deliver a functional copy of a therapeutic gene into human liver cells, thereby expressing a persistent functional level of the missing or dysfunctional protein into a patient’s bloodstream. It is advancing FLT201, a differentiated gene therapy candidate that delivers a novel transgene, in a Phase 1/2 clinical trial in people with Gaucher disease type 1. Therapeutic AAV vectors consist of two main components: the capsid and the expression cassette (that contains the gene and the promoter). It has additional programs in research, including one focused on GBA1-linked Parkinson’s disease that leverages the same novel transgene as FLT201.
Find out what a historical investment in Freeline Therapeutics Holdings plc would be worth today using our FRLN stock calculator.
Market Capitalisation
-
Price-earnings ratio
-
Dividend yield
-
Volume
-
High today
-
Low today
-
Open price
-
52-week high
-
52-week low
-
Ready to start your investing journey with Stake?
Open an accountHow do I buy FRLN shares in Australia?
Buying FRLN shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Freeline Therapeutics Holdings plc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in FRLN
What is the ticker symbol of Freeline Therapeutics Holdings plc?
The ticker symbol for Freeline Therapeutics Holdings plc is FRLN.
How much is one share of FRLN?
One share of FRLN is valued at $6.48 as of 16 May 2026.
What is the market capitalisation of Freeline Therapeutics Holdings plc FRLN?
As of 16 May 2026 Freeline Therapeutics Holdings plc has a market cap of -.
What is the 52-week high for Freeline Therapeutics Holdings plc stock?
The Freeline Therapeutics Holdings plc 52-week high stock price is $NaN.
What is the 52-week low for Freeline Therapeutics Holdings plc stock?
The Freeline Therapeutics Holdings plc 52-week low stock price is $NaN.
Can I buy FRLN shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy FRLN shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in FRLN on Stake
- Buy FRLN from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of FRLN from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
FRLN related stocks